Literature DB >> 27990608

Development and validation of a new questionnaire measuring treatment satisfaction in patients with non-valvular atrial fibrillation: SAFUCA®.

Miguel A Ruiz1, José Ramón González-Porras2, José Luis Aranguren3, Eduardo Franco4, Fernando Villasante5, José Tuñón6, Tomás José González-López7, Marina de Salas-Cansado8, Javier Soto8.   

Abstract

OBJECTIVE: To develop a new questionnaire with good psychometric properties to measure satisfaction with medical care in patients with non-valvular atrial fibrillation.
METHOD: The initial instrument was composed of 37 items, arranged in 6 dimensions: efficacy, ease and convenience, impact on daily activities, satisfaction with medical care, undesired effects of medication, and overall satisfaction. Items and dimensions were extracted from reviewing existing instruments, 3 focus groups with chronic patients, and a panel of 8 experts. Additionally, 3 visual analog scales measuring quality of life, effectiveness, and overall satisfaction were administered. A convenience sample of 119 patients was used for item reduction. Classic psychometric theory and item analysis techniques were used (exploratory factor and confirmatory factor analysis, test-retest, and correlation with visual scales). A validation sample of 230 patients was used to assess convergent validity, and an additional 220 patients sample was used to discriminate between treatment and compliance groups.
RESULTS: The questionnaire was reduced in length to 25 items, but the impact dimension had split in treatment inconvenience and treatment control. Overall reliability was high (α = 0.861) with acceptable dimensional reliabilities (α = 0.764-0.908). Individual dimensions correlated to varying degrees. Test-retest correlations were high (r = 0.784-0.965), and correlations with visual and already validated scales were substantial. Differences were detected between antivitamin K and new-oral-anticoagulant treatments in several dimensions (p < 0.05). Treatment satisfaction was related with compliance.
CONCLUSION: This new 25-item questionnaire has good psychometric properties for measuring satisfaction with medical care in patients with this condition. It is capable of detecting differences between different treatments.

Entities:  

Keywords:  Anticoagulants; Non-valvular atrial fibrillation; Questionnaire; Treatment satisfaction

Mesh:

Substances:

Year:  2016        PMID: 27990608     DOI: 10.1007/s11136-016-1474-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  20 in total

Review 1.  Antithrombotic therapy in atrial fibrillation.

Authors:  G W Albers; J E Dalen; A Laupacis; W J Manning; P Petersen; D E Singer
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

Review 2.  Progress for stroke prevention with atrial fibrillation: emergence of alternative oral anticoagulants.

Authors:  Michael Katsnelson; Ralph L Sacco; Mauro Moscucci
Journal:  Stroke       Date:  2012-04       Impact factor: 7.914

Review 3.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

Review 4.  Systematic overview of warfarin and its drug and food interactions.

Authors:  Anne M Holbrook; Jennifer A Pereira; Renee Labiris; Heather McDonald; James D Douketis; Mark Crowther; Philip S Wells
Journal:  Arch Intern Med       Date:  2005-05-23

5.  [Cross-cultural adaptation of a questionnaire for measuring the quality of life of patients taking oral anticoagulants].

Authors:  R Sánchez González; M Yanes Baonza; A Cabrera Majada; J M Ferrer García-Borrás; R Alvarez Nido; E Barrera Linares
Journal:  Aten Primaria       Date:  2004-10-31       Impact factor: 1.137

6.  Patient satisfaction with warfarin- and non-warfarin-containing thromboprophylaxis regimens for atrial fibrillation.

Authors:  Craig I Coleman; Stacey M Coleman; Julie Vanderpoel; Winnie Nelson; Jennifer A Colby; Jennifer M Scholle; Jeffrey Kluger
Journal:  J Investig Med       Date:  2013-06       Impact factor: 2.895

7.  Development and validation of the "Treatment Satisfaction with Medicines Questionnaire" (SATMED-Q).

Authors:  Miguel A Ruiz; Antonio Pardo; Javier Rejas; Javier Soto; Fernando Villasante; José L Aranguren
Journal:  Value Health       Date:  2008-05-20       Impact factor: 5.725

8.  The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients.

Authors:  Stefan J Cano; Donna L Lamping; Luke Bamber; Sarah Smith
Journal:  Health Qual Life Outcomes       Date:  2012-09-26       Impact factor: 3.186

9.  Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL).

Authors:  Xavier Badia; Fernando Arribas; Jose Miguel Ormaetxe; Rafael Peinado; Miguel Sainz de Los Terreros
Journal:  Health Qual Life Outcomes       Date:  2007-07-04       Impact factor: 3.186

10.  A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation.

Authors:  Greg Samsa; David B Matchar; Rowena J Dolor; Ingela Wiklund; Ewa Hedner; Gail Wygant; Ole Hauch; Cheryl Beadle Marple; Roger Edwards
Journal:  Health Qual Life Outcomes       Date:  2004-05-06       Impact factor: 3.186

View more
  1 in total

1.  Development of a New Patient-Reported Medication Adherence Instrument: Concerns Influencing Medication Adherence.

Authors:  Sonal Ghura Mansukhani; Elizabeth A MacLean; Laura L Manzey; Carl J Possidente; Joseph C Cappelleri; Linda S Deal
Journal:  Patient Prefer Adherence       Date:  2021-09-09       Impact factor: 2.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.